Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months

Clinical trial NCT07505836 · RECRUITING

Trial details

NCT number: NCT07505836
Sponsor: Sinovac Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Epidemic Meningitis Meningococcal Vaccines

Start date: 2026-03-22
Primary completion: 2027-01-01
Enrollment: 1040

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.